WAKE FOREST UNIVERSITY HEALTH SCIENCES

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer

First Posted Date
2004-11-09
Last Posted Date
2021-09-29
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
236
Registration Number
NCT00096356
Locations
๐Ÿ‡บ๐Ÿ‡ธ

MBCCOP - JHS Hospital of Cook County, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Central Illinois, Decatur, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Beaumont, Royal Oak, Michigan, United States

and more 28 locations

Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

First Posted Date
2004-09-03
Last Posted Date
2018-08-10
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
136
Registration Number
NCT00002942
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Phase 2
Completed
Conditions
First Posted Date
2004-08-11
Last Posted Date
2018-08-10
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
25
Registration Number
NCT00002865
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix

Phase 1
Terminated
Conditions
First Posted Date
2004-06-11
Last Posted Date
2018-08-10
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
15
Registration Number
NCT00084890
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia

Phase 2
Completed
Conditions
First Posted Date
2004-05-19
Last Posted Date
2017-01-19
Lead Sponsor
Wake Forest University Health Sciences
Registration Number
NCT00082940
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

St. Joseph Hospital Regional Cancer Center - Orange, Orange, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cancer Care Specialists, Houma, Louisiana, United States

and more 8 locations

Gemcitabine in Treating Patients With Advanced Colorectal Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-04-13
Last Posted Date
2021-09-09
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
15
Registration Number
NCT00007943
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

Phase 1
Completed
Conditions
First Posted Date
2004-04-12
Last Posted Date
2017-01-19
Lead Sponsor
Wake Forest University Health Sciences
Registration Number
NCT00003840
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Phase 2
Completed
Conditions
First Posted Date
2004-03-09
Last Posted Date
2021-09-09
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
18
Registration Number
NCT00079092
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Central Illinois, Decatur, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Upstate Carolina, Spartanburg, South Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Greenville, Greenville, South Carolina, United States

and more 2 locations

Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Phase 1
Completed
Conditions
First Posted Date
2003-11-26
Last Posted Date
2018-08-10
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
40
Registration Number
NCT00003202
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States

Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment

Phase 2
Completed
Conditions
First Posted Date
2003-11-05
Last Posted Date
2017-01-19
Lead Sponsor
Wake Forest University Health Sciences
Registration Number
NCT00072579
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Columbus, Columbus, Ohio, United States

๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Upstate Carolina, Spartanburg, South Carolina, United States

and more 12 locations
ยฉ Copyright 2024. All Rights Reserved by MedPath